Glenmark Pharmaceuticals Ltd vs Jeena Sikho Lifecare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Glenmark Pharmaceuticals Ltd is ₹ 2034 as of 17 Feb 12:23 . The P/E Ratio of Glenmark Pharmaceuticals Ltd changed from 13.5 on March 2021 to 41.5 on March 2025 . This represents a CAGR of 25.18% over 5 yearsThe P/E Ratio of Jeena Sikho Lifecare Ltd changed from 11.8 on March 2023 to 0 on March 2025 . This represents a CAGR of -100.00% over 3 years The Market Cap of Glenmark Pharmaceuticals Ltd changed from ₹ 13108 crore on March 2021 to ₹ 43458 crore on March 2025 . This represents a CAGR of 27.09% over 5 yearsThe Market Cap of Jeena Sikho Lifecare Ltd changed from ₹ 400.11 crore on March 2023 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 3 years The revenue of Glenmark Pharmaceuticals Ltd for the Dec '25 is ₹ 3945 crore as compare to the Sep '25 revenue of ₹ 6247 crore. This represent the decline of -36.85% The revenue of Jeena Sikho Lifecare Ltd for the Dec '25 is ₹ 224.25 crore as compare to the Sep '25 revenue of ₹ 191.29 crore. This represent the growth of 17.23% The ebitda of Glenmark Pharmaceuticals Ltd for the Dec '25 is ₹ 729.88 crore as compare to the Sep '25 ebitda of ₹ 1175 crore. This represent the decline of -37.89% The ebitda of Jeena Sikho Lifecare Ltd for the Dec '25 is ₹ 103.29 crore as compare to the Sep '25 ebitda of ₹ 93.47 crore. This represent the growth of 10.51% The net profit of Glenmark Pharmaceuticals Ltd changed from ₹ 340.24 crore to ₹ 403.23 crore over 7 quarters. This represents a CAGR of 10.19% The net profit of Jeena Sikho Lifecare Ltd changed from ₹ 15.73 crore to ₹ 66.6 crore over 7 quarters. This represents a CAGR of 128.11% The Dividend Payout of Glenmark Pharmaceuticals Ltd changed from 4.28 % on March 2021 to 4.38 % on March 2025 . This represents a CAGR of 0.46% over 5 yearsThe Dividend Payout of Jeena Sikho Lifecare Ltd changed from 8.19 % on March 2023 to 14.99 % on March 2025 . This represents a CAGR of 22.32% over 3 years .

About Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Limited was incorporated on November 18, 1977.
The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity).
It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets.
The Company's research and development facilities are located at Mahape, Sinnar and Taloja and manufacturing facilities are located at Nasik, Colvale, Baddi, Nalagarh, Sikkim, Indore and Aurangabad in India. The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology, Respiratory and Dermatology.
Its branded generics business has a significant presence in markets across emerging economies including India.

About Jeena Sikho Lifecare Ltd

Jeena Sikho Lifecare Limited was originally incorporated as a Private Limited Company as 'Jeena Sikho Lifecare Private Limited' dated May 29, 2017 issued by the Registrar of Companies, Delhi.
Subsequently, the Company got the status converted into Public Limited Company and the name was changed to 'Jeena Sikho Lifecare Limited' dated July 05, 2021, via fresh Certificate of Incorporation. Jeena Sikho Lifecare Limited is a renowned Ayurvedic healthcare company headquartered in Zirakpur, Punjab.
The Company is one of the leading ayurvedic healthcare system providers in India.
The Company is selling more than 250 Herbal/ Ayurvedic products.
The Company conducts various health checkup camps, yoga sessions to make people aware of their health problems as well.

FAQs for the comparison of Glenmark Pharmaceuticals Ltd and Jeena Sikho Lifecare Ltd

Which company has a larger market capitalization, Glenmark Pharmaceuticals Ltd or Jeena Sikho Lifecare Ltd?

Market cap of Glenmark Pharmaceuticals Ltd is 68,294 Cr while Market cap of Jeena Sikho Lifecare Ltd is 8,908 Cr

What are the key factors driving the stock performance of Glenmark Pharmaceuticals Ltd and Jeena Sikho Lifecare Ltd?

The stock performance of Glenmark Pharmaceuticals Ltd and Jeena Sikho Lifecare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Glenmark Pharmaceuticals Ltd and Jeena Sikho Lifecare Ltd?

As of May 5, 2026, the Glenmark Pharmaceuticals Ltd stock price is INR ₹2420.05. On the other hand, Jeena Sikho Lifecare Ltd stock price is INR ₹716.7.

How do dividend payouts of Glenmark Pharmaceuticals Ltd and Jeena Sikho Lifecare Ltd compare?

To compare the dividend payouts of Glenmark Pharmaceuticals Ltd and Jeena Sikho Lifecare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.